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Abstract
Group B streptococci (GBS) are Gram-positive bacteria that cause
infections in utero and in newborns. We recently showed that the
GBS pigment is hemolytic and increased pigment production
promotes bacterial penetration of human placenta. However, mech-
anisms utilized by the hemolytic pigment to induce host cell lysis
and the consequence on fetal injury are not known. Here, we show
that the GBS pigment induces membrane permeability in artificial
lipid bilayers and host cells. Membrane defects induced by the GBS
pigment trigger K+ efflux leading to osmotic lysis of red blood cells or
pyroptosis in human macrophages. Macrophages lacking the NLRP3
inflammasome recovered from pigment-induced cell damage. In a
murine model of in utero infection, hyperpigmented GBS strains
induced fetal injury in both an NLRP3 inflammasome-dependent and
NLRP3 inflammasome-independent manner. These results demon-
strate that the dual mechanism of action of the bacterial pigment/
lipid toxin leading to hemolysis or pyroptosis exacerbates fetal injury
and suggest that preventing both activities of the hemolytic lipid is
likely critical to reduce GBS fetal injury and preterm birth.
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Introduction
Preterm birth and early onset neonatal infections are estimated to
cause approximately 1.4 million neonatal deaths annually (Weston
et al, 2011). Currently, there is no effective therapy for prevention
of in utero infections, preterm births, and stillbirths. An important
pathogen that causes perinatal and neonatal infections is Group B
streptococci (GBS) or Streptococcus agalactiae. GBS are b-hemolytic,
Gram-positive bacteria that are typically found as recto-vaginal colo-
nizers in healthy adult women (Badri et al, 1977; Dillon et al,
1982). However, ascending in utero GBS infection increases the risk
of preterm, premature rupture of membranes (PPROM), fetal injury,
and preterm birth (Matorras et al, 1989). As ascending infections
cannot be treated by intrapartum antibiotic prophylaxis, new strate-
gies are needed to more effectively treat and prevent in utero infec-
tions and early onset GBS disease. To develop such strategies, it is
paramount to gain a better understanding of GBS virulence factors
and how they impact the host immune response.
An important virulence determinant of GBS is the toxin known
as b-hemolysin/cytolysin (hereafter referred to as the hemolysin).
This toxin is responsible for the characteristic zone of b-hemolysis
exhibited by GBS, and hemolytic strains are associated with viru-
lence (Liu et al, 2004; Fettucciari et al, 2006; Costa et al, 2012).
Also, hyperhemolytic GBS such as those deficient in the two compo-
nent system CovR/S (due to absence of repression of the hemolysin
biosynthesis operon) are significantly more pathogenic, while non-
hemolytic GBS are severely attenuated (Sendi et al, 2009; Lembo
et al, 2010). Despite these advances, studies aimed at understanding
the mechanism of action of the GBS hemolysin were confounded by
difficulties associated with purifying the toxin. Although previously
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suggested to be a protein toxin (Marchlewicz & Duncan, 1981; Pritzlaff
et al, 2001), we recently showed that the molecule responsible for
hemolytic activity of GBS is the ornithine rhamnopolyene lipid/
pigment (Whidbey et al, 2013) also known as granadaene (Rosa-
Fraile et al, 2006). With the identification of the GBS hemolysin as a
lipid, understanding how the toxin itself contributes to inflamma-
tion, cytotoxicity, and preterm birth is critical for development of
neutralizing strategies against the lipid toxin. Previous studies that
were performed with hemolytic extracts of GBS had contaminating
proteins (Marchlewicz & Duncan, 1981); consequently, the exact
mechanisms of pigment-induced cytotoxicity are unclear.
Mechanisms that promote ascending GBS infection and the
immune responses invoked during this process also remain poorly
defined. Studies using pregnant animal models have shown that
intrauterine inflammation caused by bacterial infection triggers
disruption of placental membranes leading to fetal injury and
preterm birth (Elovitz & Mrinalini, 2004; Equils et al, 2009;
Vanderhoeven et al, 2014). A study using intraperitoneal injection of
heat-killed GBS showed that a pan-caspase inhibitor was able to
delay, but not prevent, preterm birth in a murine model (Equils
et al, 2009). Although hemolytic GBS strains have been described
to activate the NLRP3 inflammasome in murine dendritic cells and
macrophages (Costa et al, 2012; Gupta et al, 2014), whether the
hemolytic pigment/lipid toxin is sufficient for inflammasome acti-
vation and whether this leads to pyroptosis are not known.
Recently, when exogenous GBS RNA was transfected into murine
macrophages, the NLRP3 inflammasome was described to associ-
ate with GBS RNA, but inflammasome activation required the
presence of hemolytic GBS (Gupta et al, 2014); however, the rele-
vance of these findings to GBS infection in vitro and in vivo is
unclear. Because NLRP3 activation occurs only in the presence of
hemolytic GBS (Costa et al, 2012; Gupta et al, 2014), we aimed to
understand how the purified GBS pigment activates the inflamma-
some, induces cell death, and establish the consequence on fetal
injury.
Here, we demonstrate that the purified GBS pigment/lipid toxin
induces membrane permeabilization and the efflux of intracellular
potassium which triggers osmotic lysis in red blood cells and
NLRP3 inflammasome and caspase 1 activation leading to pyropto-
sis in macrophages. In a pregnant murine model of intrauterine
infection, hyperhemolytic/hyperpigmented GBS strains increased
the incidence of preterm birth and in utero fetal death (IUFD) in
both an NLRP3 inflammasome-dependent and NLRP3 inflamma-
some-independent manner. Collectively, these findings provide
novel insight into how a bacterial lipid toxin/pigment mediates
cell death and demonstrates its relevance to bacterial infection and
preterm birth.
Results
The GBS lipid toxin lyses red blood cells using a colloidal
osmotic mechanism
Previous work from our group demonstrated that hyperhemolytic
GBS strains penetrate human placenta and can be associated with
women in preterm labor (Whidbey et al, 2013). We further showed
that hemolytic activity of GBS is due to the ornithine rhamnolipid
pigment (see structure in Fig 1A, (Rosa-Fraile et al, 2006)) and not
due to any protein toxin (Whidbey et al, 2013). Despite these find-
ings, the mechanism of how the hemolytic pigment/lipid toxin
causes hemolysis, cytolysis, and inflammation-mediated cell death
was not known. To understand how the pigment/lipid toxin lyses
host cells, we first examined pigment-mediated lysis of human red
blood cells (RBCs). We hypothesized that the pigment may lyse
RBC either by the mechanism of direct lysis where the lipid itself
dissolves the membrane as observed with detergents or by the
mechanism of colloidal osmotic lysis where the lipid forms pores or
causes membrane perturbations and lysis occurs via osmotic pres-
sure. To determine how the GBS pigment induces cell lysis, we first
measured the kinetics of both K+ and hemoglobin (Hb) release
from RBC treated with 400 nM pigment. As a control, an equal
amount of extract from a non-hemolytic strain of GBS (ΔcylE) was
included. The results shown in Fig 1B indicate that while the
pigment induced the release of both K+ and Hb from RBC, efflux of
the smaller K+ ion was faster than efflux of the larger Hb, as
measured by time to 50% release (Fig 1B; 4.8 min versus 8.4 min;
P < 0.0001, extra sum-of-squares F test). These results suggest that
the pigment induces membrane permeabilization that allows K+
ions to efflux, followed by the release of Hb. The slight lag in
release of Hb versus K+ suggests a colloidal osmotic mechanism of
lysis by the GBS pigment, rather than rapid dissolution of the
membrane by direct lysis wherein no lag is expected between K+
and Hb. A similar lag between K+ and Hb release was observed
during hemolysis mediated by Staphylococcus aureus a-toxin
(Supplementary Fig S1A), whereas 100% release of both K+ and Hb
occurred instantly with direct lysis mediated by Triton X-100
(Supplementary Fig S1B).
We also performed protection assays with osmoprotectants of
various sizes ranging from a hydrodynamic radius of 0.40 nm
(PEG200) to 1.6 nm (PEG3000). To this end, human RBCs were pre-
treated with the GBS pigment for 2 min and the RBCs were pelleted
to remove any unincorporated pigment. Pigment-treated RBCs were
then resuspended in PBS or PBS containing 30 mM osmoprotectant,
and hemolytic activity was measured (for details, see Materials and
Methods). The results shown in Fig 1C indicate that smaller osmo-
protectants such as PEG200 and PEG400 did not protect RBC from
pigment-mediated hemolysis, whereas complete protection from
hemolysis was observed in the presence of the larger osmoprotec-
tants such as PEG1500 and PEG3000. In comparison, minimal
protection was observed with SDS, which causes direct and instant
lysis of RBC (Supplementary Fig S2).
The GBS hemolytic lipid induces membrane permeabilization of
artificial lipid bilayers
To determine if membrane permeability observed with the GBS
pigment requires the active cellular response of host cells, we tested
the ability of the pigment to disrupt artificial lipid bilayers using
model black lipid membranes (BLMs). BLMs mimic membrane lipid
bilayers but lack the active cellular responses of host cells. To test
our hypothesis, BLM composed of 1,2-diphytanoyl-sn-glycero-3-
phosphocholine (DPhPC) was established across an aperture sepa-
rating two chambers of a U-tube as previously described Butler et al
(2008). A voltage was applied, and current was measured between the
two chambers; an increase in current corresponds to a compromise in
ª 2015 The Authors EMBO Molecular Medicine Vol 7 | No 4 | 2015






Figure 1. Colloidal osmotic lysis and membrane permeabilization caused by the GBS pigment/lipid toxin.
A The GBS pigment also known as granadaene is an ornithine rhamnopolyene (Rosa-Fraile et al, 2006).
B Human red blood cells (RBCs) were incubated with 400 nM pigment or control DcylE extract, and kinetics of K+ and Hb release was monitored. Data shown are the
average and SEM of six independent experiments. The time to 50% K+ and 50% Hb release with pigment was 4.8 min and 8.4 min, respectively; n = 6, P < 0.0001,
extra sum-of-squares F test.
C Role of osmoprotectants in pigment-treated RBC. Human RBCs were pre-incubated with GBS pigment for 2 min at RT, centrifuged, and resuspended in the presence
and absence of 30 mM osmoprotectant with hydrodynamic radius of 0.40 nm (PEG200), 0.56 nm (PEG400), 0.89 nm (PEG1000), 1.1 nm (PEG1500), or 1.6 nm
(PEG3000), respectively. Release of Hb was measured after 1 h of incubation at 37°C. Data shown are the average and SEM of three independent experiments.
D Characteristics of membrane permeabilization by the GBS pigment in artificial lipid bilayers. Lipid bilayers were generated using diphytanoylphosphatidylcholine
(DPhPC) and treated with either 2 lM pigment or an equivalent amount of the control DcylE extract. In the pigment-treated sample, channel conductance indicating
disruption of the membrane is seen within 45 s. Erratic and non-discrete fluctuations in current are observed, suggesting the formation of multiple, small membrane
defects. The bilayer eventually breaks at 120 s. In lipid bilayers treated with the control DcylE extract, the mean ionic current trace remains constant at 0 pA, showing
no membrane disruption. Data shown are representative of three independent experiments.
EMBO Molecular Medicine Vol 7 | No 4 | 2015 ª 2015 The Authors
EMBO Molecular Medicine GBS pigment-mediated fetal injury Christopher Whidbey et al
490
membrane integrity. We observed that treatment of BLMs with
pigment resulted in an increase in measured current, while treat-
ment with the control DcylE extract resulted in no change (data from
2 lM are shown in Fig 1D and from 75 nM are shown in Supple-
mentary Fig S3). Interestingly, jumps were erratic in both frequency
and magnitude. The initial compromised bilayer area was in the
order of 1 nm2. Subsequently, the size of the compromise in the
bilayer fluctuated frequently before the bilayer finally ruptured at
either 120 s (Fig 1D) or 345 s (Supplementary Fig S3), depending
on pigment concentration. The increase in conductance observed in
the lipid bilayers due to the GBS pigment is not canonical with
either the formation of discrete protein pores that are usually
marked by well-defined jumps in membrane conductance or
detergent-mediated bilayer solubilization, which is marked by a rapid
increase in conductance followed by spontaneous disappearance of
the entire membrane (Supplementary Fig S3). The changes in
conductance fluctuations are consistent with the pigment intercalat-
ing into and perforating the bilayer; this appears to be a dynamic
process in which channel conductance appears and disappears.
Taken together, these data demonstrate that the membrane perme-
ability observed in pigment-treated cells occurs independently of a
cellular response and is unique in its mode of action by neither
conforming to a typical pore-forming protein toxin nor inducing
instant lysis as observed with detergents.
Purified GBS lipid toxin/pigment is sufficient for induction of IL-1b
release and cytolysis
To understand how the hemolytic pigment triggers host cell death,
we examined the pro-inflammatory and cytotoxic properties elicited
by the purified hemolytic pigment. In these experiments, we also
included GBS strains with differences in hemolytic activity such as
GBS WT A909, isogenic hyperhemolytic/hyperpigmented strain
ΔcovR (lacking the two component regulator CovR/S that represses
biosynthesis of the hemolytic pigment), and non-hemolytic ΔcylE,
ΔcovRΔcylE strains that were derived from WT and ΔcovR but lack
the cylE gene important for pigment biosynthesis (for details, see
(Whidbey et al, 2013)). Given that macrophages are important for
defense against GBS infections, we utilized macrophages derived
from M-CSF-treated human peripheral blood mononuclear cells
(PBMC) as well as differentiated THP-1 cells as models of human
macrophage-like cells. Human PBMC and THP-1-derived macro-
phages were treated with GBS WT, hyperhemolytic DcovR, and non-
hemolytic DcylE and DcovRDcylE at a multiplicity of infection (MOI)
of 1 for 4 h, and cytotoxicity was measured by LDH release. The
results shown in Figs 2A and 3A show that LDH release indicative
of cell death was significantly higher in macrophages treated with
hyperhemolytic GBS when compared to non-hemolytic strains. We
also observed that hyperhemolytic GBS induced significantly more
IL-1b release when compared to the isogenic non-hemolytic strains
(Figs 2B and 3B).
To determine the importance of the pigment/lipid toxin in the
pro-inflammatory and cytotoxic nature of GBS, the human PBMC-
and THP-1-derived macrophages were incubated with various
concentrations of purified pigment or control DcylE extract for 4 h,
and cytotoxicity was measured as the loss of metabolic activity as
measured by a redox dye, alamar blue. Cytotoxicity due to GBS
pigment was dose dependent and 50% cell death was observed at
approximately 1–2 lM (Figs 2C and 3C), which is noticeably higher
than the EC50 for RBC (< 0.1 lM, Fig 1C). This observation is likely
due to the membrane turnover that occurs in macrophages and not
RBC, and has also been observed with other bacterial exotoxins
(Keyel et al, 2011).
To identify the pathways activated by the purified GBS pigment/
lipid toxin, we measured cytokine levels in the supernatants of
pigment-treated macrophages. Interestingly, levels of IL-1b were
significantly increased in pigment-treated PBMC and THP-1 cells
compared to control DcylE extract-treated cells (Figs 2D and 3D).
Consistent with the above observations, IL-18 levels were also
increased in pigment-treated THP-1 macrophages, but other pro-
inflammatory cytokines such as TNFa, IL-6, and IFN-c were not
significantly increased (Supplementary Fig S4). Taken together,
these data show that the purified hemolytic GBS pigment is pro-
inflammatory and cytotoxic.
Pigment-induced cytotoxicity and immune response are NLRP3
inflammasome dependent
The increase in secretion of IL-1b and IL-18 observed in human
macrophages treated with GBS pigment suggests that the pigment
can trigger activation of the inflammasome. The inflammasome is a
cytosolic complex, which mediates cleavage of pro-caspase 1 to
active caspase 1, which in turn cleaves pro-IL-1b and pro-IL-18 into
their active forms. One major inflammasome comprises the NLR
(nucleotide binding, leucine-rich repeat containing) protein known
as NLRP3, which associates with the adaptor ASC (apoptosis-associated
speck-like protein containing the caspase recruitment domain,
CARD) (Taxman et al, 2010). To determine if the GBS pigment/lipid
toxin activates NLRP3, we exposed previously characterized THP-1
human macrophage cell lines that were constitutively knocked
down for expression of NLRP3 or the adapter protein ASC ((Willing-
ham et al, 2007), Supplementary Fig S5) to GBS strains (WT,
isogenic DcovR, DcylE, DcovRDcylE) or purified pigment. As controls,
THP-1 macrophages transfected with empty vector or a shRNA of
scrambled ASC sequence were included. The results shown in
Fig 4A indicate that GBS induced significant cell death in macro-
phages containing the NLRP3 inflammasome in a hemolysin-dependent
manner. Notably, cell death was significantly decreased in macrophage
cell lines knocked down for expression of NLRP3 or ASC (Fig 4A).
Similarly, hemolytic and hyperhemolytic GBS strains induced
increased IL-1b secretion in macrophages in an NLRP3 inflammasome-
dependent manner (Fig 4B). Consistent with these observations, we
observed that increasing concentrations of the purified GBS hemo-
lytic pigment induced cell death and IL-1b secretion in an NLRP3
inflammasome-dependent manner (Fig 4C and D). These results
demonstrate that in macrophages, the GBS hemolytic pigment
primarily induces an NLRP3 inflammasome-dependent programmed
cell death. The cell death observed in NLRP3-deficient macrophages
with hyperpigmented GBSΔcovR (25–40%, see THP-1/shASC,
THP-1/shNLRP3 in Fig 4A) could not be prevented by the addition
of osmoprotectants such as PEG1500 or by the caspase 3/7 inhibitor
Z-DEVD-FMK (Supplementary Fig S6). Also, levels of IL-1b released
by THP-1/shASC and THP-1/shNLRP3 cells exposed to GBSΔcovR
were not significantly different from cells exposed to GBS WT, ΔcylE,
or ΔcovRΔcylE (Fig 4B). Based on these observations, we predict that
the residual cell death observed in inflammasome-deficient cells due
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to hyperpigmented GBS can be attributed to an inflammasome- and
caspase 3/7-independent pathway, as suggested previously with rat
neuronal cells (Reiss et al, 2011).
The GBS pigment induces membrane permeabilization and
loss of intracellular potassium independent of the
NLRP3 inflammasome
A known activator of the NLRP3 inflammasome is the efflux of
intracellular potassium that occurs upon membrane permeabiliza-
tion (Munoz-Planillo et al, 2013). Given that the GBS pigment is
able to induce membrane disruptions in RBC and even in artificial
lipid bilayers (Fig 1C and D), we hypothesized that intercalation of
the GBS pigment into host cells such as human macrophages should
trigger membrane permeabilization and the efflux of intracellular
potassium, irrespective of the presence or absence of the inflamma-
some. To test this hypothesis, we measured membrane disruption
and quantified intracellular potassium levels in NLRP3-proficient
and NLRP3-deficient macrophages that were treated with the GBS
pigment. To examine membrane permeabilization, we exposed
NLRP3-proficient and NLRP3-deficient macrophages to GBS pigment
(1 lM) or controls for 20 min and measured uptake of a membrane
impermeable dye, propidium iodide (see Materials and Methods for
details). The results shown in Fig 5A and B indicate that increased
fluorescence is seen in both NLRP3-proficient and NLRP3-deficient
macrophages treated with GBS pigment (1 lM) when compared to
controls (ΔcylE extract). These data indicate that the GBS pigment
induces membrane permeability in host cells independent of the
inflammasome. To further confirm this, we utilized ion-coupled
plasma atomic emission spectroscopy (ICP-AES) as described
(Munoz-Planillo et al, 2013) to measure levels of intracellular potas-
sium in NLRP3-proficient and NLRP3-deficient macrophages that
were exposed to GBS pigment or to controls over time (0, 30, 60,
120, 180, and 240 min). These results demonstrate that intracellular
potassium levels dramatically decreased within 30 min in NLRP3-
proficient macrophages (THP-1/scrambled, Fig 5C) and in NLRP3-
deficient macrophages (THP-1/shNLRP3, Fig 5D) that were exposed
to the GBS pigment (1 lM), demonstrating that both pigment-mediated
membrane disruption and potassium efflux occur independently of





































































































Figure 2. The GBS pigment toxin/lipid toxin is pro-inflammatory and cytotoxic to primary human macrophages.
A, B PBMC-derived macrophages were treated with GBS WT, DcylE, DcovR, or DcovRDcylE at an MOI of 1 and incubated for 4 h. Cytotoxicity was measured by LDH
release (A), and IL1b release in supernatants was measured by ELISA (B).
C, D PBMC-derived macrophages primed with 100 ng/ml LPS for 3 h were incubated with various concentrations of GBS pigment or control DcylE extract for 4 h.
Cytotoxicity was measured by alamar blue assay (C), and IL1b release from pigment- or DcylE extract-treated cells was measured by Luminex assay (D).
Data information: Data shown are the average of four independent experiments performed in triplicate, error bars  SEM. Significance was determined using
Bonferroni’s multiple comparison test following ANOVA. (A) n = 4, *P = 0.021 for WT versus DcovR; *P = 0.01 for DcovR versus DcovRDcylE. (B) n = 4, *P = 0.031 for WT
versus DcovR; *P = 0.036 for DcovR versus DcovRDcylE. (C) n = 4, ****P < 0.0001, **P = 0.002. (D) n = 4, **P = 0.005.
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NLRP3-deficient macrophages appear to be able to recover from the
initial K+ efflux (see 120, 180, and 240 min in Fig 5D). In contrast,
cells proficient for NLRP3 undergo cell death and do not signifi-
cantly recover (Fig 5C). To determine if K+ efflux was important for
pigment-induced cell death, we performed cytolysis assays of THP-1
cells exposed to the GBS pigment in the presence of excess extracel-
lular potassium (final concentration 50 mM) compared to culture
media containing 5 mM potassium. The results shown in Fig 5E
indicate that addition of extracellular potassium partially protected
the cells from GBS pigment-mediated cytolysis, further supporting a
role of K+ efflux and NLRP3 activation in cytolysis.
The GBS pigment induces caspase 1-dependent pyroptosis
Activation of the NLRP3 inflammasome by K+ efflux leads to
activation of caspase 1 (Petrilli et al, 2007; Jin & Flavell, 2010; Davis
et al, 2011; Munoz-Planillo et al, 2013). To determine if the GBS
pigment-mediated K+ efflux induced caspase 1 activation, we
utilized a membrane permeable, caspase 1-specific FLICA reagent
(fluorochrome-labeled inhibitors of caspases, 660-YVAD-FMK;
Immunochemistry Technologies) that binds to active caspase 1. We
observed that in macrophages expressing NLRP3, pigment treatment
resulted in more FLICA+ cells when compared to pigment treatment
of macrophages that were knocked down for NLRP3 expression
(Fig 6A). Collectively, these results show that the GBS pigment trig-
gers potassium efflux and NLRP3 inflammasome-mediated caspase 1
activation. Active caspase 1 can trigger the pro-inflammatory
programmed cell death known as pyroptosis, a type of cell death
that has been increasingly associated with bacterial pathogenesis
(LaRock & Cookson, 2013). To determine if the GBS pigment
induces cell death by pyroptosis, we utilized the caspase 1-specific
inhibitor Z-YVAD-FMK. We observed that when THP-1 macrophages
were pre-treated with the caspase 1-specific inhibitor, they were
significantly more resistant to pigment-mediated cell death (Fig 6B),
whereas protection from pigment-mediated cell death was not
observed with the caspase 3/7 inhibitor Z-DEVD-FMK or vehicle
only (Fig 6B). Also, increasing the concentration of the caspase 1-
specific inhibitor Z-YVAD-FMK provided dose-dependent protection
from pigment-mediated cell death and complete protection was seen
at 200 lM Z-YVAD-FMK (Supplementary Fig S7). The requirement
A B
C D
Figure 3. The GBS pigment toxin/lipid toxin is pro-inflammatory and cytotoxic to immortalized THP-1 monocyte-derived macrophages.
A, B WT THP-1 macrophages were treated with GBS WT, DcylE, DcovR, or DcovRDcylE at an MOI of 1 and incubated for 4 h. Cytotoxicity was measured by LDH release
(A), and IL1b release in supernatants was measured by Luminex assay (B).
C, D WT THP-1 macrophages were incubated with various concentrations of GBS pigment or control DcylE extract for 4 h. Cytotoxicity was measured by alamar blue
assay (C), and IL1b release from pigment- or DcylE extract-treated cells was measured by Luminex assay (D).
Data information: Data from three independent experiments performed in triplicate are shown, error bars  SEM. Significance was determined using Bonferroni’s
multiple comparison test following ANOVA. (A) n = 3, **P = 0.0080 for WT versus DcovR; **P = 0.0016 for DcovR versus DcovRDcylE. (B) n = 3, *P = 0.03 for WT versus
DcovR; *P = 0.02 for DcovR versus DcovRDcylE. (C) n = 3, ****P < 0.0001. (D) n = 3, *P = 0.01.
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of K+efflux, NLRP3, ASC, caspase 1, and the ensuing pro-inflammatory
response demonstrates that GBS utilizes a hemolytic pigment/lipid
toxin to induce pyroptosis.
The GBS pigment causes fetal injury by NLRP3 inflammasome-
dependent and NLRP3 inflammasome-independent mechanisms
Previous work from our group demonstrated that hyperhemolytic
GBS strains with mutations in CovR/S were more proficient in
penetration of human placenta and were also isolated from
chorioamniotic membranes and amniotic fluid from women in
preterm labor (Whidbey et al, 2013). To determine if hyperhemolytic
GBS strains induce fetal injury and preterm birth, we adapted a
murine model of E. coli-induced in utero infection (Elovitz et al,
2003) to GBS. We chose the intrauterine model of inoculation rather
than a vaginal model of inoculation to minimize discrepancies that
can be attributed to differences in mouse vaginal persistence (Patras
et al, 2013). To this end, on day E14.5 of pregnancy, either WT
GBS, the hyperpigmented ΔcovR, or the non-hemolytic ΔcovRΔcylE
was infused into the right horn of the uterus between the first (P1)
and second (P2) fetal sacs most proximal to the cervix as described
(Hirsch et al, 1995; Elovitz et al, 2003) (also see Fig 7A). Mice were
monitored for 72 h for signs of preterm birth (i.e., at least 1 pup in
cage). At either 72 h or at the onset of delivery (whichever occurred
first), fetal survival rates were determined and tissue was collected
to assess bacterial load. Preterm birth (i.e., at least 1 pup in cage)
was observed in three of six mice infected with DcovR, in one of six
infected with WT GBS, and in none of the six mice infected with
the non-hemolytic DcovRDcylE strain (preterm delivery rates were






































































































































Figure 4. The GBS pigment induces NLRP3 inflammasome-dependent cell death in human macrophages.
A, B THP-1 macrophages transfected with empty vector, scrambled control, shASC, or shNLRP3 were treated with GBS WT, DcylE, DcovR, or DcovRDcylE at an MOI of 1
and incubated for 4 h. Cytotoxicity was measured by LDH release (A), and IL1b release in supernatants was measured by Luminex assay (B). Data from three
independent experiments performed in triplicate are shown.
C, D The shRNA THP-1macrophages were incubated with various concentrations of GBS pigment or DcylE extract for 4 h. Cytotoxicity was measured by alamar blue
assay (C), and IL1b release in supernatants was measured by Luminex assay (D). Pigment-mediated cytotoxicity is dependent on the NLRP3 inflammasome components,
suggesting that pigment is inducing a programmed cell death. Data shown are the average of at least three independent experiments performed in triplicate.
Data information: Data were analyzed using Bonferroni’s multiple comparison test following ANOVA, error bars  SEM. (A) n = 3, for WT: **P = 0.001 (vector versus
shNLRP3), **P = 0.0016 (vector versus shASC); for DcovR: ***P = 0.0008 (vector versus shNLRP3), ***P = 0.0001 (vector versus shASC), *P = 0.047 (scrambled versus
shNLRP3), **P = 0.0054 (scrambled versus shASC). Data obtained from THP-1/vector was not significantly different from THP-1/scrambled, P = 0.18. (B) n = 3, *P = 0.025.
Data obtained from THP-1/vector were not significantly different from THP-1/scrambled, P = 0.89. (C) n = 3, for 4 lM pigment: **P = 0.0063 (vector versus shNLRP3),
**P = 0.0035 (vector versus shASC), *P = 0.01 (scrambled versus shNLRP3), **P = 0.009 (scrambled versus shASC); for 2 lM pigment: **P = 0.0088 (vector versus
shNLRP3), **P = 0.0066 (vector versus shASC), *P = 0.01 (scrambled versus shNLRP3 or shASC); for 1 lM pigment: *P = 0.02 (vector versus shNLRP3), *P = 0.01 (vector
versus shASC). Data obtained from THP-1/vector were not significantly different from THP-1/scrambled, P = 0.99. (D) n = 3, ****P < 0.0001, *P = 0.015.
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fetal death in mice infected with hemolytic GBS, that is, WT or
hyperpigmented ΔcovR compared to the non-hemolytic DcovRDcylE
strain (Fig 7B). Bacteria were recovered from all fetuses present in
the uterus, and there was no significant difference in bacterial load
between fetuses of mice infected with the three GBS strains (data




Figure 5. GBS pigment induces membrane permeabilization and K+ efflux independently of the NLRP3 inflammasome.
A, B THP-1 macrophages proficient for NLRP3 (transfected with scrambled control, A) or deficient for NLRP3 (shNLRP3, B) were treated with 1 lM pigment or DcylE
extract for 20 min, and propidium iodide (PI) was added during the final 10 min. PI uptake was measured by flow cytometry, and data shown are representative of
two independent experiments.
C, D Intracellular potassium concentration was measured by ICP-AES. THP-1 macrophages transfected with the scrambled control (C) or shNLRP3 (D) were treated with
GBS pigment (1 lM) or an equivalent amount of the DcylE extract. At various time points, cells were lysed and intracellular [K+] was measured relative to
untreated cells (see bars and left y-axis), and percent cell death was quantified by alamar blue (see squares, dotted connecting lines and right y-axis). Both NLRP3-
proficient and NLRP3-deficient macrophages initially lose intracellular K+ due to GBS pigment (compare t = 0 min to t = 30 min), but the NLRP3-deficient cells
(shNLRP3) are able to recover, while the scrambled control do not, demonstrating that initial K+ loss occurs independently of NLRP3. Data are average of three
independent experiments performed with independent pigment preparations in triplicate and were analyzed using Dunnett’s multiple comparison test following
ANOVA; all data were compared to control at t = 0, error bars  SEM. (C) n = 3, ***P = 0.0002, *P = 0.019, **P = 0.0032 for 120 min, **P = 0.0072 for 180 min.
(D) n = 3, **P = 0.0043, *P = 0.031. (E) WT THP-1 macrophages were incubated with pigment in media containing either 5 mM or 50 mM potassium chloride, and
cytotoxicity was measured by alamar blue assay. The addition of potassium chloride is able to protect the macrophages from cytolysis, demonstrating that K+
efflux is essential for this process. Data shown are three independent experiments performed in triplicate and were analyzed using Bonferroni’s multiple
comparison test following ANOVA, error bars  SEM (n = 3, ****P < 0.0001, **P = 0.0036).
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while only a few mononuclear cells are present in the ΔcovRΔcylE
sample, increased presence of inflammatory cells and necrotic
debris is seen in the ΔcovR sample (Fig 7C). The frequency of fetal
death between hemolytic strains of GBS such as WT and ΔcovR was
not significantly different and may likely be due to decreased
repression of hemolysin/pigment biosynthetic genes by CovR/S in
utero as suggested previously (Santi et al, 2009; Sitkiewicz et al,
2009).
To determine if hemolysis and/or activation of the NLRP3
inflammasome is important for fetal injury and preterm birth
caused by hyperhemolytic GBS strains, we utilized pregnant homo-
zygous NLRP3 knockout (NLRP3KO) mice (Brydges et al, 2009;
Kovarova et al, 2012) in the in utero model of infection described
above. We compared the frequency of preterm birth and fetal
death in pregnant WT C57BL6 and NLRP3KO mice that were
infected in utero with either hyperhemolytic GBSDcovR or isogenic
non-hemolytic GBSΔcovRΔcylE. Notably, preterm delivery was
observed in three of six WT C57BL6 mice infected with DcovR and
not in any other groups, that is, WT C57BL6 mice infected with
DcovRDcylE or NLRP3KO mice infected with either DcovR or
DcovRDcylE. The results shown in Fig 7D indicate that GBS infec-
tion-mediated fetal death can be associated with production of the
hemolytic pigment (compare DcovR and DcovRDcylE in WT
C57BL6 mice) and the presence of the NLRP3 inflammasome
(compare DcovR in WT C57BL6 and NLRP3KO mice). Fetal death
was also significantly higher in NLRP3KO mice infected with
DcovR compared to NLRP3KO mice infected with DcovRDcylE;
these results indicate that the hemolytic/membrane-disrupting
nature of the pigment (without NLRP3 inflammasome activation)
is also likely to contribute to fetal injury. Both hemolytic and non-
hemolytic GBS were able to penetrate all fetuses located through-
out the uterus in both WT and NLRP3KO mice (Fig 7E), indicating
that decreased fetal death observed in the inflammasome-deficient
mice or due to non-hemolytic/non-pigmented GBS strains cannot
be attributed to decreased bacterial dissemination. Of note, fetal
death observed in NLRP3KO mice due to non-hemolytic GBS is not
significantly different when compared to WT C57BL6 mice
(P > 0.3, Fig 7D) or CD-1 mice (P = 1 compare Fig 7D to B). IL-1b
levels were significantly higher in WT C57BL6 mice infected with
DcovR compared to NLRP3KO mice infected with DcovR or WT
mice infected with DcovRDcylE (Fig 7F). As IL-1b levels were
not significantly different between NLRP3KO mice infected with
DcovR or DcovRDcylE, these results suggest that the GBS pigment
primarily activates the NLRP3 inflammasome in vivo. IL-1b levels
in WT C57BL6 mice infected with DcovRDcylE were higher than
NLRP3KO mice infected with DcovRDcylE, suggesting that
additional factors besides the pigment also activate the NLRP3
inflammasome, but interestingly, this did not correlate to increased
fetal death. Collectively, our results indicate that production of the
hemolytic pigment contributes to GBS infection-associated fetal
injury in both an NLRP3 inflammasome-dependent and NLRP3
inflammasome-independent manner and places the hemolytic
pigment as a critical component of GBS fetal injury.
Discussion
This study demonstrates how the GBS hemolytic pigment/lipid
toxin causes cell death, triggers inflammation, and promotes fetal
injury. Although the hemolytic nature of GBS was described
almost a century ago (Brown, 1920; Rosa-Fraile et al, 2014) and is
associated with virulence of the pathogen (Pritzlaff et al, 2001;
Doran et al, 2003; Liu et al, 2004; Hensler et al, 2005; Lembo
et al, 2010), mechanistic insight into this potent virulence factor
was lacking. We recently showed that the molecular basis of
hemolytic activity in GBS is the pigment/lipid toxin (Whidbey
BA
Figure 6. The GBS hemolytic pigment/lipid toxin induces caspase 1 activation and pyroptosis.
A THP-1 macrophages were treated with GBS pigment, and caspase 1 activation was measured by flow cytometry using a FLICA reagent. Pigment treatment of the
scrambled shRNA control cell line induces more caspase 1 activation compared to the shNLRP3 cell line, demonstrating that the pigment activates caspase 1
exclusively through the NLRP3 inflammasome. Results are representative of three independent experiments.
B WT THP-1 macrophages were treated with the caspase 1 inhibitor Z-YVAD-FMK, the caspase 3/7 inhibitor Z-DEVD-FMK, or DMSO only prior to treatment with the
GBS pigment. YVAD is able to significantly decrease cytotoxicity in cells treated with GBS pigment, demonstrating that caspase 1 is required for GBS pigment-
mediated cell death, characteristic of pyroptosis, while DEVD had no effect. Data are average of three independent experiments, error bars  SEM. Significance was
determined using Bonferroni’s multiple comparison test following ANOVA (n = 3, ****P < 0.0001, ***P = 0.0002, *P = 0.014).
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et al, 2013). In the current study, we utilized artificial lipid
bilayers, RBC, and macrophages to understand how a bacterial
pigment/lipid toxin disrupts these host cells. The trans-membrane
conductance observed in artificial lipid bilayers suggests that the
pigment/lipid toxin does not induce the formation of large, multi-
meric pores (commonly observed with protein toxins) but rather
induces membrane permeabilization by forming variably sized
membrane defects similar to those previously observed with the
cyclic antimicrobial peptide, Gramicidin S (Ashrafuzzaman et al,
2008). The predicted length of the polyene moiety of the GBS
pigment is approximately 32 Å (determined using a molecular
model generated by the National Cancer Institute’s Online SMILES
Translator and modeled using PyMol), which is similar to the aver-
age thickness of the plasma membrane at 30–40 Å (Schrodinger,
2010). Thus, we predict that insertion of the GBS hemolytic
pigment may span the host cell membrane, with the rhamnose
and ornithine moieties acting as polar head groups. Insertion of
the GBS pigment into RBC membranes triggers membrane disrup-
tion leading to colloidal osmotic lysis (see proposed model in
Fig 8).
Unlike RBC, most host cells have the capability to turnover their
plasma membrane which can confer some protection against
membrane-disrupting bacterial toxins (Keyel et al, 2011). Although
such a defense mechanism may prevent the toxin from directly kill-
ing the cell, the initial membrane disruption can activate immune
pathways such as the NLRP3 inflammasome. Our data demonstrate
that this is the case for the GBS hemolytic pigment. After likely
intercalating into the plasma membrane, the GBS pigment triggers
membrane permeability leading to ion flux. In the presence of TLR
signaling (Henneke & Berner, 2006), this initiates activation of the
NLRP3 inflammasome leading to caspase-1 activation, increased
IL-1b and IL-18 secretion, and the programmed cell death known as
pyroptosis (see proposed model in Fig 8). We demonstrate that the
GBS pigment is sufficient for inflammasome activation. Previous
work indicated that hemolytic GBS strains activate the NLRP3
inflammasome in mouse dendritic cells (Costa et al, 2012) and
recently, RNA was implicated in hemolysin-mediated NLRP3 activa-
tion (Gupta et al, 2014). However, the extraction and isolation
procedures followed for purification of the GBS pigment (Rosa-Fraile
et al, 2006; Whidbey et al, 2013) should remove any contaminating
nucleic acid. In addition, we did not observe the presence of nucleic
acid in purified pigment samples that were analyzed directly and
subsequent to RT–PCR on ethidium bromide-stained agarose gels
(Supplementary Fig S8). Furthermore, NMR data of purified pigment
(Whidbey et al, 2013) did not reveal the presence of imino protons’
characteristic of RNA (Furtig et al, 2003). Also, we did not detect
any protein on pigment samples analyzed on Sypro Ruby-stained
SDS–PAGE (Supplementary Fig S8). As the purified GBS pigment,
which is devoid of nucleic acids, activates the NLRP3 inflammasome
and induces pyroptosis, these results suggest that GBS pigment can
induce pyroptosis even in the absence of RNA. These conclusions
are also supported by our observations that inactive pigment (pig-
ment lacking the carrier molecule starch) is not hemolytic and does
not activate the NLRP3 inflammasome or induce pyroptosis (Supple-
mentary Fig S9). These data also indicate that background absor-
bance values from the pigment do not confound analysis of cell
death or cytokines.
Activation of the inflammasome likely leads to a more robust
immune response that is programmed for pathogen clearance.
Indeed, the presence of the NLRP3 inflammasome was shown to be
critical for bacterial clearance in a murine model of GBS sepsis
(Costa et al, 2012). In such a model, activation of the inflamma-
some was clearly beneficial to the host. However, activation of a
robust inflammatory response can be detrimental during pregnancy,
leading to tissue damage and perinatal complications. While
increased IL-1b has been associated with chorioamnionitis, fetal
injury, and preterm birth (Sadowsky et al, 2006; Flores-Herrera
et al, 2012; Jaiswal et al, 2013), mechanistic insight into microbial
factors that trigger inflammasome activation and the consequence
on fetal injury and preterm birth was not known. Furthermore, a
large number of studies on preterm birth have utilized either puri-
fied PAMPs that trigger TLRs such as LPS or peptidoglycan (Robertson
et al, 2006; Breen et al, 2012; Jaiswal et al, 2013), heat-killed bacte-
ria (Equils et al, 2009; Filipovich et al, 2009), or direct infusion of
cytokines into the amniotic fluid (Sadowsky et al, 2006; Kallapur
et al, 2013) to ascribe the role of cytokines and other host factors in
infection-associated preterm birth. However, these strategies fail to
completely recapitulate the events that occur during bacterial
Figure 7. The GBS pigment causes fetal injury by NLRP3 inflammasome-dependent and NLRP3 inflammasome-independent mechanisms.
Female pregnant wild-type (CD-1, C57BL6) or NLRP3-deficient mice were injected in utero with 106–7 CFU of GBS WT, DcovR, or DcovRDcylE and monitored for preterm birth.
Surgery and GBS inoculation for each pregnant mouse were performed independently. Data shown are representative of experiments with 6 animals per group for each GBS
strain and two animals were used for saline controls.
A Scheme of pup numbering in utero and injection site between fetuses P1 and P2 is shown.
B In utero fetal death in wild-type CD-1 mice due to infection with GBS WT, hyperhemolytic DcovR, and non-hemolytic DcovRDcylE. Fetal death is represented by the
number of dead fetuses/total number of fetuses obtained from six pregnant mice per group. ‘n’ indicates total number of pups (both live and dead); ****P < 0.0001,
Fisher’s exact test.
C H&E staining of uterine tissue. Open arrow indicates the presence of few mononuclear cells, whereas filled arrows indicate increased infiltration of inflammatory cells
and necrotic debris.
D Fetal death due to infection with hyperhemolytic GBS DcovR and non-hemolytic DcovRDcylE in WT C57BL6 and NLRP3 inflammasome-deficient mice; fetal death is
represented by the number of dead fetuses/total number of fetuses obtained from 6 pregnant mice per group. ‘n’ indicates total number of pups (both live and dead);
*P = 0.011, **P = 0.0015, ****P < 0.0001, Fisher’s exact test. Fetal death due to DcovRDcylE in WT C57BL6 and NLRP3KO mice was not significant and is indicated as
NS; P = 0.31, Fisher’s exact test.
E Bacterial burden in fetal pups and uterine horns from mice infected with the various GBS strains (n = 6/pup; of note, pups that were delivered preterm were excluded
from CFU enumeration. Scheme of pup numbering is shown in (A). RUH and LUH indicate right uterine horn and left uterine horn, respectively. CFUs are not
significantly different between any of the groups (ANOVA, P = 0.6, error bars  SEM).
F IL-1b levels in GBS-infected tissues (placenta and fetus, n = 6/group) was measured by Luminex assay (*P = 0.025, ***P = 0.0002, ****P < 0.0001, Bonferroni’s
multiple comparison test following ANOVA). IL-1b levels was not significantly different in NLRP3KO mice infected with DcovR compared to NLRP3KO mice infected
with DcovRDcylE mice and is indicated as NS; P = 0.99.
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infections in utero. In a murine model of in utero GBS infection, we
observed that hemolytic and hyperhemolytic strains induce preterm
birth and cause significantly more fetal death than non-hemolytic
strains, similar to recent observations in a vaginal model of ascend-
ing GBS infection (Randis et al, 2014). Our results comparing preg-
nant WT and NLRP3-deficient mice suggest that pigment-mediated
activation of the NLRP3 inflammasome enhances GBS infection-
associated fetal injury. Thus, contrary to the benefits of inflammasome
activation during systemic GBS infection, inflammasome activation
appears to be detrimental during pregnancy. The balance between
these two requirements—the necessity of inflammation to protect
the mother from infection and the necessity of an anti-inflammatory
environment to promote fetal survival—is critical to maternal and
child health.
Our studies also reveal that GBS pigment-mediated fetal injury is







EMBO Molecular Medicine Vol 7 | No 4 | 2015 ª 2015 The Authors
EMBO Molecular Medicine GBS pigment-mediated fetal injury Christopher Whidbey et al
498
data indicate that the hemolytic nature of the pigment is also likely
to contribute to fetal injury. This can be expected as the pigment
more efficiently lyses RBC (EC50 < 0.1 lM) when compared to IL-1b
induction (0.25 lM) or pyroptosis (1–2 lΜ). It is also likely that
inflammasome- and caspase 3/7-independent mechanisms contrib-
ute to GBS infection-associated fetal injury. Taken together, these
data suggest that prevention of fetal injury and preterm birth caused
by infection of hyperhemolytic GBS strains cannot solely be
achieved by inhibition of inflammasome or caspase inhibitors.
Rather, the generation of analogues or vaccines that prevent
pigment-mediated hemolysis and pyroptosis may be necessary for
prevention of GBS-associated host injury and preterm birth.
Although our studies comparing GBS-induced fetal death in
NLRP3KO mice and WT C57BL6J were performed using the hyper-
pigmented GBSDcovR and isogenic non-pigmented GBSDcovRDcylE,
we have previously shown that the hypervirulent phenotype of
GBSDcovR in a murine model of systemic infection (Lembo et al,
2010) and for penetration of human placenta (Whidbey et al, 2013)
is reversed when the gene cylE important for hemolytic pigment
production (Pritzlaff et al, 2001; Whidbey et al, 2013) is deleted in
the GBSDcovR mutant (Lembo et al, 2010; Whidbey et al, 2013).
Furthermore, deletion of cylE in GBSDcovR did not restore the
expression of CAMP factor, a CovR-activated gene (Lembo et al,
2010). Nevertheless, as CovR/S is a global regulator in GBS,
secondary effects although unexpected are still plausible.
Given that potent nature of the pigment, it is beneficial for patho-
gens such as GBS, which typically exist as commensals in the lower
genital tract, to repress pigment expression to minimize host injury.
It is likely that under certain conditions of environmental stress
(e.g., changes in pH, (Santi et al, 2009; Sitkiewicz et al, 2009)), GBS
utilizes signaling systems such as CovR/S to alleviate repression of
pigment genes leading to barrier disruption and ascending infection.
Understanding how pathogen-encoded lipid toxins mediate host cell
lysis and contribute to infection and inflammation is critical for
developing preventive measures. This is relevant as opportunistic
pathogens including Bacillus cereus contain genes homologous to
those encoding the GBS hemolytic pigment/ lipid toxin (Whidbey
et al, 2013), and other rhamnolipid toxins are produced by patho-
gens such as Pseudomonas aeruginosa and Burkholderia pseudomallei
(Haussler et al, 1998; Zulianello et al, 2006). It is also likely that
other pathogens encode hemolytic and cytolytic lipid toxins, but
these are yet to be discovered. In summary, we show that the GBS
Figure 8. Proposed model on GBS pigment-mediated host cell lysis and preterm birth.
The GBS pigment intercalates into host cell membranes leading tomembrane permeability and ion flux. In RBC, this leads to colloidal osmotic lysis. Inmacrophages, the loss of
intracellular potassium serves as a trigger for NLRP3 inflammasome formation. The activated inflammasome then activates caspase 1, which cleaves pro-IL-1b and pro-IL-18
to their active forms. Finally, caspase 1 activation causes cell death by pyroptosis. While NLRP3-dependent pyroptosis is the major form of cell death observed in macrophages
exposed to purified pigment and hemolytic/pigmented GBS strains, hyperpigmented GBS strains induced low levels of cell death in NLRP3-deficient and ASC-deficient
macrophages that were independent of inflammasome and caspase 3/7. In host cells that are either resistant or recover from pigment-induced membrane damage
(e.g., NLRP3-deficient macrophages), we predict that lysosomal degradation of pigment or shedding of vesicles that contain pigment–membrane complexes and the turnover
of plasma membrane prevents cell death. The GBS pigment exacerbates fetal injury and preterm birth through the combined action of colloidal osmotic lysis and pyroptosis.
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hemolytic pigment functions as a double-edged sword causing
colloidal osmotic lysis or NLRP3 inflammasome activation and
pyroptosis, which together exacerbate fetal injury and preterm birth.
These findings emphasize the importance of cytotoxic lipids in fetal
injury and have important implications for prevention of GBS
pigment-mediated fetal injury and preterm births.
Materials and Methods
Ethics statement
Written informed patient consent for donation of human blood was
obtained with approval from the Seattle Children’s Research Insti-
tute Institutional Review Board (protocol # 11117) as per the Princi-
ples in the WMA Declaration of Helsinki and Dept. of Health and
Human Services Belmont Report. Children under the age of 18 were
not recruited for donation of human blood.
All animal experiments were approved by the Seattle Children’s
Research Institutional Animal Care and Use Committee (protocols
#13907 and #13311) and performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health (8th Edition). All surgery
was performed under anesthesia, and every effort was made to
minimize suffering and animal use.
Materials, bacterial strains, and cell lines
All chemicals were purchased from Sigma-Aldrich, unless otherwise
noted. Cell culture media was purchased from Fisher Scientific. The
WT GBS strains A909 and COH1 used in this study are clinical
isolates obtained from infected human newborns (Lancefield et al,
1975; Martin et al, 1988). The GBS mutants DcylE, DcovR, and
DcovRDcylE were previously derived from A909 and COH1 (Pritzlaff
et al, 2001; Rajagopal et al, 2006; Lembo et al, 2010; Whidbey et al,
2013). Routine cultures of GBS were grown in tryptic soy broth
(TSB, Difco Laboratories) at 37°C in 5% CO2. WT THP-1s were
kindly provided by Dr. Ferric C Fang. THP-1s stably transfected with
shRNA to NLRP3 (C CIAS1), ASC, or scrambled controls used in this
study have been previously described (Willingham et al, 2007;
Kebaier et al, 2012). THP-1s were routinely cultured in RPMI with
10% fetal bovine serum as described (Willingham et al, 2007;
Kebaier et al, 2012).
Purification of the GBS pigment
GBS pigment was purified as previously described (Whidbey et al,
2013). Briefly, pigment was extracted from WT GBS A909 using
DMSO:0.1% TFA, precipitated using NH4OH and column-purified
using a Sephadex LH-20 (GE Healthcare) column as described
(Rosa-Fraile et al, 2006; Vanberg et al, 2007; Whidbey et al, 2013).
Fractions containing purified pigment were pooled, precipitated
with NH4OH, washed three times with HPLC-grade water, twice
with DMSO, and lyophilized as described Whidbey et al (2013). As
a control, pigment extraction protocol was performed on the
GBSDcylE strain and the extract was used as a control in all experi-
ments. The purified pigment was tested for the presence of pigment
using mass spec and NMR with DcylE extract as negative controls as
described previously (Whidbey et al, 2013). Samples of pigment
were also analyzed on protein and agarose gels to confirm the lack
of DNA, RNA, and protein contaminants. For hemolytic and
cytotoxic assays, lyophilized pigment or control DcylE extract was
dissolved in DMSO containing 0.1%TFA and 20% starch (Difco;
DTS) to a final concentration of 200 lM. The samples were
incubated overnight at room temperature in the dark prior to use.
Hemolysis assays
Hemolysis assays with purified GBS pigment were performed using
human red blood cells as described previously (Whidbey et al,
2013). For osmotic protection assays, RBCs were pre-incubated with
purified pigment for 2 min at room temperature. Cells were then
pelleted by centrifugation as described (Vanberg et al, 2007), and
the supernatant was extracted to remove unintercalated pigment.
The RBCs were then resuspended in PBS or PBS containing a
30 mM solution of osmoprotectant of hydrodynamic radius 0.40 nm
(PEG200), 0.56 nm (PEG400), 0.89 nm (PEG1000), 1.1 nm
(PEG1500), or 1.6 nm (PEG3000) (Kuga, 1981; Vanberg et al, 2007)
and incubated for 1 h at 37°C. Because SDS-mediated lysis occurred
instantly which prevented pre-incubation with RBC, SDS was added
to the resuspended RBC, which was then incubated for an hour.
Hemoglobin and potassium efflux kinetics
To measure kinetics of hemoglobin and potassium release, human
blood was centrifuged and washed three times in potassium-free
PBS and resuspended to 2% RBC in potassium-free PBS. RBCs were
diluted 1:1 with potassium-free PBS in a beaker and continuously
stirred on a magnetic stir plate. At time 0, either 400 nM GBS
pigment or an equivalent amount of control DcylE extract or
0.47 lM Staphylococcus aureus a-toxin (Calbiochem) was added.
The concentration of free potassium in the supernatant at each time
point was measured using an ion-specific electrode as per manufac-
turer’s protocol (Cole Parmer Combination Ion Specific Electrode,
EW-27504-26). Hemoglobin release was measured by centrifuging a
120-ll aliquot of the mix for 2 min at 1,200 g and measuring the
absorbance of the supernatant at 420 nm. Percent release was
calculated using the formula Percent Release = (value-minimum) /
(maximum-minimum) × 100, where the minimum was the value at
t = 0, and the maximum was the value obtained via lysis
with Triton X-100 (Sanchez et al, 2010). A sigmoidal nonlinear
regression was performed using the Prism software (GraphPad) to
determine the time to 50% release.
Conductance measurements through lipid bilayers
The single-channel conductance of the GBS pigment was analyzed
on a custom-made lipid bilayer apparatus described previously
(Butler et al, 2008). To test how the pigment alters membrane stability,
we used lipid bilayers or black lipid membranes (BLMs) composed
of 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC; Avanti
Polar Lipids) as the model. Lipid bilayers or BLMs were generated
as previously described (Butler et al, 2008). Briefly, the reaction
vessel was a Teflon block with two wells connected by a ‘U-tube.’
One end of this U-tube was closed except for a 20-lm aperture,
which was painted with DPhPC dissolved in hexadecane. The wells
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and tube were filled with buffer (0.3 M KCl, 10 mM HEPES, pH to
7.4  0.05) and a pipette was used to blow and retract a 10-ll air
bubble atop the lipid-painted aperture, producing the BLM as a
barrier between the two chambers of the tube. A voltage (180 mV)
was applied to the system, and current was measured with a patch
clamp amplifier (Axon 200B). Pigment (2 lM or 75 nM) or control
DcylE extract was added to one chamber, and changes in current
were monitored for 10 min. As controls, BLMs were incubated with
either the pore-forming toxin MspA (0.51 nM; (Butler et al, 2008))
or the detergent sodium dodecyl sulfate (350 lM).
Derivation of primary macrophages from human blood
Peripheral blood mononuclear cells (PBMC) were isolated using
methods previously described (Yarilina et al, 2011). Briefly, 60 ml
of blood was collected from independent healthy human donors into
heparinized tubes. The human blood was diluted 1:1 with PBS, and
leukocytes were isolated using UNI-SEP maxi tubes (NOVAmed)
following manufacturer’s instructions. Briefly, UNI-SEP maxi tubes
were spun at 1,000 g for 20 min and the mononuclear cell layer was
retrieved using a pipette. The isolated cells were then washed with
RPMI 1640, and selection for CD14+ cells was performed using the
MACS magnetic separation columns (Miltenyi Biotec) as per manu-
facturer’s instructions. Subsequently, the CD14+ cells were seeded in
96-well tissue culture plates at 1 × 105 cells/well in 100 ll RPMI
160 supplemented with 10% FBS containing 100 IU/ml penicillin,
100 lg/ml streptomycin, and 20 ng/ml macrophage colony-stimulating
factor (M-CSF)-1 (Life Technologies). The tissue culture media was
replaced on day 5 and on day 7, and PBMC-derived macrophages
were directly infected with GBS strains or primed with LPS
(100 ng/ml) for 3 h before exposure to purified pigment (see
below).
Derivation of macrophages from THP-1 monocytic cells
For treatment of THP-1-derived macrophages with GBS or pigment,
undifferentiated THP-1 monocytes were resuspended in media
containing 100 nM phorbol 12-myristate 13-acetate (PMA) and
seeded at 105 cells/well into 96-well plates as described (Harrison
et al, 2005; Holzinger et al, 2012). After 2 days of incubation, media
were replaced with PMA-free media, were incubated overnight, and
were exposed to either GBS strains or purified pigment as described
below.
Cytolysis assays
PBMC-derived macrophages and THP-1-derived macrophages from
above were used to measure the cytolytic activity of the GBS strains
or purified GBS pigment. For bacterial infection, PBMC- and THP-1-
derived macrophages were infected with mid-log phase GBS
(O.D600 nm = 0.3) at an MOI (multiplicity of infection) of 1 for 4 h.
Cytolysis was measured by LDH release (LDH kit, Clontech) as per
manufacturer’s instructions. For pigment-mediated cytolysis, cells
were washed four times with PBS and treated with serum-free
media containing GBS pigment (0.125–4 lM). DTS alone or DcylE
extracts were used as controls. After 4 h of incubation, supernatants
were removed for cytokine analysis, and the media were replaced
with TC media containing serum and alamar blue (Life Technologies).
After 2 h of incubation, the fluorescence in each well was
measured as per manufacturer’s protocol, using a BioTek Plate
Reader.
For both bacterial- and pigment-mediated cytolysis, percent of
dead cells was calculated by normalizing to untreated cells (0%
killing) or cells treated with 1% Triton X-100 (100% killing).
For experiments with the caspase 1 inhibitor, 50–200 lM
Z-YVAD-FMK (R&D Systems), 100 lM Z-DEVD-FMK (Cayman
Chemical), or equivalent amount of control DMSO were added to
THP-1 cells, 1 h prior to addition of pigment or controls.
Measurement of cytokine production
Supernatants from the cytolysis assays (see above) were used for
cytokine analysis by either Luminex assay (Affymetrix) or ELISA
(IL-1b: R&D Systems; IL-18: MBL) as per the manufacturer’s
instructions.
Measurements of caspase-1 activation and
membrane permeabilization
Activation of caspase 1 and changes in membrane permeability due
to GBS pigment were measured using flow cytometry (LSRII, BD
Biosciences). Briefly, THP-1 cells grown on non-TC-treated plates
were washed and resuspended to 5–10 × 105 cells/ml in TC media
lacking serum. For membrane permeabilization assays, uptake of the
membrane impermeable dye propidium iodide (PI, Life Technolo-
gies) was measured. Briefly, THP-1 cells were treated for 30 min with
1 lM pigment or an equal volume of control DcylE extract. PI was
added in the last 10 min of incubation, and uptake was measured by
flow cytometry as per the manufacturer’s instructions. PI+ popula-
tions were identified compared to an untreated sample. Data are
representative of two independent experiments with independent
preparations of pigment. For caspase 1 activation assays, cells were
incubated with 1 lM pigment or an equal volume of control DcylE
extract for 1 h. 660-YVAD-FMK (Immunochemistry Technologies)
was then added, and incubation was continued for another hour.
Caspase 1 activation was measured by flow cytometry as per the
manufacturer’s instructions. FLICA+populations were identified, and
percent FLICA+ cells were calculated. Data shown are representative
of three independent experiments with independent preparations of
pigment. Data were collected with the FACSDiva software and were
analyzed using the FlowJo software system.
Quantification of intracellular potassium concentration
Intracellular potassium concentration was measured by ion-coupled
plasma–atomic emission spectroscopy (ICP-AES) as previously
described (Munoz-Planillo et al, 2013). Briefly, THP-1 cells in
12-well plates (106 cells/well, seeded in 1 ml) were treated as
described above with 1 lM pigment. At various time points (0, 30,
60, 120, 180, 240 min), supernatant was removed and wells were
washed with 1 ml potassium-free PBS. Subsequently, 1 ml of 3%
HNO3 was added to the wells to free intracellular potassium and
incubated for 30 min. One millilitre of HPLC-grade water was then
added, and samples were analyzed by ICP-AES (Perkin Elmer
Optima 8300). Percent intracellular potassium was calculated
relative to an untreated sample.
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Murine model of intrauterine GBS infection
Wild-type CD-1-, C57BL6/J-, or NLRP3-deficient mice (Brydges
et al, 2009; Kovarova et al, 2012) were used. Mice were obtained
from Jackson Laboratories or Charles River Laboratory, USA, and
were housed at the Seattle Children’s Research Institute Vivarium
in accordance with the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health (8th Edition). Mice at
6–10 weeks of age were bred in-house for time-mated pregnancy.
During mating, a female was paired individually with a male.
Infected pregnant mice were housed individually. Intrauterine infec-
tions of pregnant female mice were performed as previously
described (Hirsch et al, 1995; Elovitz et al, 2003) with a few modifi-
cations. Briefly, on day E14.5 of pregnancy, dams were anesthetized
using isoflurane, and a midline laparotomy was performed to
expose uterine horns as described previously (Hirsch et al, 1995;
Elovitz et al, 2003). Bupivacaine (1–2 mg/kg) was infused along
the incision site to provide local anesthesia. Dams were infected
with 100 ll of 106–7 CFU of GBS into the right uterine horn between
the first (P1) and second (P2) fetal sacs most proximal to the cervix
(also see Fig 7A). After inoculation, sterile saline was applied to the
exposed uterus, and the uterus was returned to the abdomen. The
muscle and skin layers were closed using absorbable suture as
described (Hirsch et al, 1995; Elovitz et al, 2003), and dams were
returned to their cage and monitored every 12 h for signs of
preterm delivery. Three days post-infection or at the onset of
preterm birth (vaginal bleeding and pups in cage), animals were
placed under deep isoflurane anesthesia and repeated laparotomy
was performed. Preterm birth was defined as delivery of at least
one pup before this time point. In utero fetal death (IUFD) was
identified by white discoloration and fetal resorption, and % fetal
death was calculated using the formula: (# of dead fetuses) / (total
# of fetuses) × 100. Fisher’s exact test was used to compare statisti-
cal differences in fetal death by comparing number of dead to
number of live fetuses obtained from six pregnant mice in each
group. Bacterial load in fetus (combined CFU obtained from
placenta and entire body of each fetus) was enumerated using serial
dilution and plating homogenized tissues. Cytokine IL-1b levels
were examined in supernatants of homogenized tissues from
placenta and fetus using Luminex assays. Portions of the right uter-
ine horn were processed for histology as described previously
(Whidbey et al, 2013). All experiments are accurately reported as
per ARRIVE guidelines.
Statistical analysis
Student’s t-test, Mann–Whitney test, Bonferroni’s multiple compari-
son test following ANOVA, or Fisher’s exact test were used to esti-
mate differences as appropriate, and P-value < 0.05 was considered
significant. The nonlinear regression analysis followed by an extra
sum-of-squares F test was used to estimate and compare time to
50% release, and P-value < 0.05 was considered significant. These
tests were performed using GraphPad Prism version 5.0 for
Windows, GraphPad Software, USA, www.graphpad.com. All in vitro
experiments were performed a minimum of three independent times
in triplicate and analyzed for significance without predetermined
assumptions. Based on the assumption that GBS infection will cause
fetal injury, animal studies were performed with an n = 6 per
group to provide an estimated statistical power ranging from 67 to
82% depending upon standard deviation at an alpha level of 5%
(~95% confidence level). Animals were randomly paired for pregnancy
The paper explained
Problem
Currently, the incidence of preterm birth and prematurity in humans
is at 30% in the United States and is much more severe in developing
countries. Preterm birth is the largest risk factor for childhood
morbidity and mortality. During human pregnancy, infection of the
amniotic fluid by microorganisms residing in the lower genital tract
leads to in utero fetal injury, preterm birth, and stillbirth. Rates of
preterm births and stillbirths are on the rise in all parts of the world.
Currently, there is no effective therapy to prevent preterm births or
stillbirths or reduce in utero fetal injury. This is in part due to the
significant lack of information on the nature of microbial factors and
host immune responses that exacerbate human pregnancy-associated
infections. Recently, we described that increased expression of the
hemolytic pigment promotes GBS penetration of human placenta.
However, mechanisms by which the pigment/lipid toxin causes hemo-
lysis and host cell lysis and consequence of fetal injury and preterm
birth were unknown. In the current manuscript, we address these
outstanding questions.
Results
Here, we show that the GBS hemolytic pigment/lipid toxin induces
small and transient membrane defects in artificial lipid bilayers, accu-
mulation of these defects results in dissolution of the membrane.
Pigment-induced membrane defects trigger potassium efflux resulting
in osmotic lysis of red blood cells (RBCs). While these behaviors are
commonly associated with pore-forming toxins, membrane permeabil-
ity observed in artificial lipid bilayers demonstrates the lack of
uniformly sized discrete ion channels in pigment-treated membranes.
Thus, the GBS pigment shows characteristics of membrane disruption
that is neither typical of pore formation nor rapid dissolution of
membranes typically observed in detergents. We also show that in
other eukaryotic cells (such as human macrophages), the GBS pigment
induces the programmed cell death known as pyroptosis. In the
absence of the NLRP3 inflammasome, pigment-mediated membrane
damage and potassium efflux are observed, but cells recover from this
initial damage and do not undergo pyroptosis. We further demon-
strate the in vivo relevance of membrane permeabilization versus
inflammasome activation by performing studies on in utero fetal
death and preterm birth using WT and NLRP3 knockout mice. These
data show that the GBS pigment utilizes a dual mechanism of action
wherein both inflammasome activation and the hemolytic/membrane
damaging nature of the pigment contribute to fetal injury. Collec-
tively, these studies provide novel mechanistic insight into how a
bacterial lipid toxin produced by GBS induces membrane permeabili-
zation, inflammation, cell death, and fetal injury.
Impact
This study demonstrates how a toxic bacterial lipid can induce hemoly-
sis and pyroptosis and how these contribute to in utero fetal injury and
preterm birth. While previous studies have indicated that the inflamma-
some is important for eradication of systemic bacterial infections, here
we show that activation of the inflammasome, in part, exacerbates GBS
fetal injury and preterm birth. Given that GBS fetal injury is also seen in
inflammasome-deficient mice, our data also suggest that mechanisms
that solely prevent caspase activation (caspase I or pancaspase inhibi-
tors) will not be sufficient to prevent GBS preterm birth as the hemolytic
nature of the toxin also contributes to fetal injury. These findings have
important implications in strategies for prevention of GBS infection-
associated fetal injury and preterm births.
EMBO Molecular Medicine Vol 7 | No 4 | 2015 ª 2015 The Authors
EMBO Molecular Medicine GBS pigment-mediated fetal injury Christopher Whidbey et al
502
and infection. No bias was introduced for infection, that is, animals
were not pre-chosen for infection with a particular GBS strain.
Analysis of fetal death was performed in an unbiased manner.
Histology sections were scored in a blinded fashion.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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